CATALENT RESPONDS TO THE GLOBAL COVID-19 OUTBREAK
We are taking decisive action to minimize the impact of the COVID-19 pandemic on our employees, partners, customers, and their patients.
With experience across more than 60 gene therapy programs and leading expertise in AAV Vectors, Catalent’s Gene Therapy team will provide you with full life cycle support of your life-saving therapeutic.
FLEXDIRECT™ DIRECT-TO-PATIENT SERVICES
With the growth in semi and fully remote clinical studies, our flexible direct-to-patient offerings enable clinical supplies to be sent directly to patients’, reducing or eliminating the need for in person clinical site visits.
With our broad range of experience and deep expertise, we have the talent and unique technologies to transform your concepts into excellent results. This is backed by our global reach, with facilities located worldwide enabling us to tailor a solution to fit your needs.
SEE ALL LOCATIONS
Join Our Team
Catalent is growing & hiring! Join the global drug development and delivery leader that puts “Patient First” at the center of our work every day. Learn more about careers at Catalent.